{"meta":{"query_hash":"9675f88f4559","filters":{"venue":"Journal of Pharmaceutics"},"cohort_total":3,"direct_labels_cover":0,"predictions_cover":3,"exported":3,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/9675f88f4559","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Pharmaceutics"},"results":[{"id":"W1983963892","doi":"10.1155/2013/103527","title":"Microencapsulation for the Therapeutic Delivery of Drugs, Live Mammalian and Bacterial Cells, and Other Biopharmaceutics: Current Status and Future Directions","year":2012,"lang":"en","type":"review","venue":"Journal of Pharmaceutics","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Biopharmaceutics; Drug delivery; Pharmaceutical technology; Nanotechnology; Pharmacology; Biochemical engineering; Chemistry; Medicine; Materials science; Engineering; Biochemistry; Biological activity; Pharmacognosy","score_opus":0.08625569136415033,"score_gpt":0.3801273506697642,"score_spread":0.2938716593056139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983963892","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025079,0.99871325,0.00024325741,0.00009408105,0.000077286655,0.000003878359,0.0000059185304,0.000007425985,0.0006040569],"genre_scores_gemma":[0.00088670786,0.99810755,0.0003683483,0.00006507655,0.000057064557,0.000005170994,0.000011478282,0.0000014864354,0.0004972581],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999801,0.000027210559,0.000022916625,0.000034750734,0.00009258036,0.000021635016],"domain_scores_gemma":[0.9997855,0.00009911595,0.000033637003,0.000008112673,0.000052965283,0.000020782094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000684086,0.00079233263,0.0013031431,0.0018964894,0.00026627394,0.0008249313,0.00071947917,0.0010389249,0.0021338917],"category_scores_gemma":[0.00039130062,0.00036975916,0.00046375126,0.0022998804,0.000417302,0.0013631703,0.0004985057,0.0011860302,0.0016406345],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000757896,0.00016378035,0.00012755858,0.014378473,0.0000663472,0.0002692677,0.00006666318,0.0005646473,0.009762732,0.0031515867,0.008949987,0.96242315],"study_design_scores_gemma":[0.000029835195,0.00023462901,0.0011180172,0.002418358,0.000121214915,0.0022895222,0.000091554735,0.0003864774,0.0052081314,0.0018464436,0.986217,0.000038773924],"about_ca_topic_score_codex":0.0008256012,"about_ca_topic_score_gemma":0.0013649826,"teacher_disagreement_score":0.0021338917,"about_ca_system_score_codex":0.00045592934,"about_ca_system_score_gemma":0.0007574228,"threshold_uncertainty_score":0.00713861},"labels":[],"label_agreement":null},{"id":"W2016731078","doi":"10.1155/2013/365635","title":"Health Technology Assessment Fireside: Antibiotic Prophylaxis and Dental Treatment in Canada","year":2012,"lang":"en","type":"review","venue":"Journal of Pharmaceutics","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Guideline; Antibiotic prophylaxis; Intensive care medicine; Context (archaeology); Population; Psychological intervention; Antibiotics; Environmental health; Nursing","score_opus":0.6977975149070008,"score_gpt":0.6418478359959107,"score_spread":0.05594967891109015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016731078","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005037171,0.9937495,0.00015064311,0.0028798396,0.00019945402,0.00011529738,0.00036266787,0.000007816302,0.0020310676],"genre_scores_gemma":[0.01680222,0.9799958,0.0014444353,0.00072721357,0.0001238306,0.00020452228,0.00029442727,0.0000035234161,0.00040400616],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9864899,0.003796042,0.0018779446,0.0004403024,0.0069293804,0.0004664714],"domain_scores_gemma":[0.9701166,0.0145977,0.0041353246,0.00029683948,0.010064486,0.0007890628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010919227,0.00089679915,0.0027368183,0.016214542,0.0013898879,0.004328326,0.0015444417,0.0018209049,0.0057882457],"category_scores_gemma":[0.05574242,0.0005005947,0.0033140965,0.021414092,0.0010822203,0.00188459,0.002020346,0.0020927468,0.00024092408],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020198384,0.000072253046,0.0056123403,0.16030261,0.0016522893,0.00011871323,0.00039949786,0.0009722488,0.0000807549,0.0065889778,0.028309103,0.7956892],"study_design_scores_gemma":[0.00044542146,0.00030473174,0.091424026,0.54511017,0.009048786,0.0006032705,0.0009860464,0.0030185052,0.0004282649,0.0060055857,0.34239003,0.00023514834],"about_ca_topic_score_codex":0.697401,"about_ca_topic_score_gemma":0.7838468,"teacher_disagreement_score":0.9507742,"about_ca_system_score_codex":0.049225815,"about_ca_system_score_gemma":0.1253932,"threshold_uncertainty_score":0.60876215},"labels":[],"label_agreement":null},{"id":"W2089635679","doi":"10.1155/2013/812387","title":"Intranasal, siRNA Delivery to the Brain by TAT/MGF Tagged PEGylated Chitosan Nanoparticles","year":2013,"lang":"en","type":"article","venue":"Journal of Pharmaceutics","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; McGill University","keywords":"Nasal administration; Biodistribution; Pharmacology; In vivo; Medicine; Toxicity; Chitosan; Blood–brain barrier; Small interfering RNA; Neurodegeneration; Chemistry; Central nervous system; In vitro; Internal medicine; Transfection; Biology; Biochemistry; Biotechnology","score_opus":0.015586439982732098,"score_gpt":0.2872528425984473,"score_spread":0.2716664026157152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089635679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97933024,0.0025859494,0.015629873,0.00017714141,0.00005327725,0.000090863476,0.00021109858,0.00017186614,0.0017497457],"genre_scores_gemma":[0.9786008,0.0020895447,0.014257165,0.00007665983,0.000018040935,0.00007649004,0.00019891236,0.000032492673,0.0046498957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999455,0.0000049647224,0.0000040955742,0.000019884892,0.00001635083,0.000009190135],"domain_scores_gemma":[0.999967,0.000004229805,0.000011959335,0.0000027808658,0.000008595645,0.0000055449195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000082159655,0.00036354674,0.00018388029,0.00016300632,0.00012595166,0.00017340438,0.00020292503,0.00026196468,0.00044080731],"category_scores_gemma":[0.000077392506,0.00010594456,0.00015404416,0.00007924309,0.00017294186,0.0001691046,0.00009425935,0.00029206037,0.00017543968],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027332731,0.000010473966,0.000027178312,0.00002712039,0.0000023685266,0.000031115094,0.000007356281,0.000071640075,0.99835324,0.00002704626,0.000030780706,0.0013842693],"study_design_scores_gemma":[0.000008060844,0.00027263022,0.00043936865,0.000004018009,0.0000136813405,0.00011896937,0.000010594365,0.00069261034,0.9976896,0.000017201797,0.0007299015,0.000003413407],"about_ca_topic_score_codex":0.0031381291,"about_ca_topic_score_gemma":0.0044035357,"teacher_disagreement_score":0.0031381291,"about_ca_system_score_codex":0.000391691,"about_ca_system_score_gemma":0.00035747618,"threshold_uncertainty_score":0.0062397122},"labels":[],"label_agreement":null}]}